Home
About
Overview
Sharing Data
ORCID
Help
History (54)
Fighting microbial drug resistance: a primer on the role of evolutionary biology in public health.
Molecular profiling of metastatic colorectal tumors using next-generation sequencing: a single-institution experience.
Chemokines and NSCLC: Emerging role in prognosis, heterogeneity, and therapeutics.
Immunotherapy in Non-Small Cell Lung Cancer Patients with Brain Metastases: Clinical Challenges and Future Directions.
Epidermal growth factor receptor mutations and susceptibility to targeted therapy in lung cancer.
See All 54 Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Epidermal growth factor receptor mutations and susceptibility to targeted therapy in lung cancer.
Epidermal growth factor receptor mutations and susceptibility to targeted therapy in lung cancer. Respirology. 2006 Nov; 11(6):687-92.
View in:
PubMed
subject areas
Antineoplastic Agents
DNA, Neoplasm
Drug Resistance, Neoplasm
Enzyme Inhibitors
ErbB Receptors
Erlotinib Hydrochloride
Gene Deletion
Gene Expression Regulation, Neoplastic
Humans
Lung Neoplasms
Mutation
Protein-Tyrosine Kinases
Quinazolines
authors with profiles
Ravi Salgia